Bionical Emas

Bionical Emas is a global Contract Research Organization (CRO) based in Paulsboro, NJ, specializing in Early Access Programs (EAP) and Clinical Trial Supply (CTS) services. The company is dedicated to accelerating patient access to innovative medicines and employs around 42 staff members, with a high employee satisfaction rate recognized as a Great Place to Work®. The company focuses on bridging the gap between pharmaceutical development and patient care through its integrated service model. Bionical Emas facilitates pre-approval access to investigational therapies for patients with unmet medical needs and manages the logistics, storage, and distribution of clinical trial materials. Their bespoke solutions cater to various therapeutic areas, including oncology, rare diseases, and immunology. Following a strategic shift in 2024, Bionical Emas aims to strengthen its market leadership in EAP and CTS while expanding its global presence and service capabilities.